179 related articles for article (PubMed ID: 31921677)
1. Dysregulation of Ketone Body Metabolism Is Associated With Poor Prognosis for Clear Cell Renal Cell Carcinoma Patients.
Cui W; Luo W; Zhou X; Lu Y; Xu W; Zhong S; Feng G; Liang Y; Liang L; Mo Y; Xiao X; Huang G; Matskova L; Zhang Z; Li P; Zhou X
Front Oncol; 2019; 9():1422. PubMed ID: 31921677
[TBL] [Abstract][Full Text] [Related]
2. ACAT1 and Metabolism-Related Pathways Are Essential for the Progression of Clear Cell Renal Cell Carcinoma (ccRCC), as Determined by Co-expression Network Analysis.
Chen L; Peng T; Luo Y; Zhou F; Wang G; Qian K; Xiao Y; Wang X
Front Oncol; 2019; 9():957. PubMed ID: 31649873
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic Inactivation of Acetyl-CoA Acetyltransferase 1 Promotes the Proliferation and Metastasis in Nasopharyngeal Carcinoma by Blocking Ketogenesis.
Lu Y; Zhou X; Zhao W; Liao Z; Li B; Han P; Yang Y; Zhong X; Mo Y; Li P; Huang G; Xiao X; Zhang Z; Zhou X
Front Oncol; 2021; 11():667673. PubMed ID: 34485115
[TBL] [Abstract][Full Text] [Related]
4. CLEC3B is downregulated and inhibits proliferation in clear cell renal cell carcinoma.
Liu J; Liu Z; Liu Q; Li L; Fan X; Wen T; An G
Oncol Rep; 2018 Oct; 40(4):2023-2035. PubMed ID: 30066941
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
[TBL] [Abstract][Full Text] [Related]
6. The mRNA Expression Signature and Prognostic Analysis of Multiple Fatty Acid Metabolic Enzymes in Clear Cell Renal Cell Carcinoma.
Zhao Z; Liu Y; Liu Q; Wu F; Liu X; Qu H; Yuan Y; Ge J; Xu Y; Wang H
J Cancer; 2019; 10(26):6599-6607. PubMed ID: 31777589
[TBL] [Abstract][Full Text] [Related]
7. ACAT1 suppresses clear cell renal cell carcinoma progression by AMPK mediated fatty acid metabolism.
Zheng M; Zhang S; Zhou J; Lin M; Liao Y
Transl Oncol; 2024 Jun; 47():102043. PubMed ID: 38909457
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of BRAF-activated long non-coding RNA is associated with the proliferation of clear cell renal cell carcinoma.
Xue S; Jiang SQ; Li QW; Wang S; Li J; Yang S; Zhang HM; Xu YF; Wang LS; Zheng JH
BMC Urol; 2018 Sep; 18(1):79. PubMed ID: 30200918
[TBL] [Abstract][Full Text] [Related]
9. miR-19a correlates with poor prognosis of clear cell renal cell carcinoma patients via promoting cell proliferation and suppressing PTEN/SMAD4 expression.
Ma Q; Peng Z; Wang L; Li Y; Wang K; Zheng J; Liang Z; Liu T
Int J Oncol; 2016 Dec; 49(6):2589-2599. PubMed ID: 27779660
[TBL] [Abstract][Full Text] [Related]
10. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.
Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X
Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578
[TBL] [Abstract][Full Text] [Related]
11. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
[TBL] [Abstract][Full Text] [Related]
12. The Landscape of Iron Metabolism-Related and Methylated Genes in the Prognosis Prediction of Clear Cell Renal Cell Carcinoma.
Mou Y; Zhang Y; Wu J; Hu B; Zhang C; Duan C; Li B
Front Oncol; 2020; 10():788. PubMed ID: 32528886
[No Abstract] [Full Text] [Related]
13. Expression of
Xiong L; Feng Y; Hu W; Tan J; Li S; Wang H
Front Genet; 2021; 12():683173. PubMed ID: 34290740
[TBL] [Abstract][Full Text] [Related]
14. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of two lipid metabolism enzymes, HADHA and ACAT2, in clear cell renal cell carcinoma.
Zhao Z; Lu J; Han L; Wang X; Man Q; Liu S
Tumour Biol; 2016 Jun; 37(6):8121-30. PubMed ID: 26715271
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma.
Shi L; Xiao L; Heng B; Mo S; Chen W; Su Z
Int Urol Nephrol; 2017 Jul; 49(7):1165-1176. PubMed ID: 28349447
[TBL] [Abstract][Full Text] [Related]
17. SDHB Suppresses the Tumorigenesis and Development of ccRCC by Inhibiting Glycolysis.
Fang Z; Sun Q; Yang H; Zheng J
Front Oncol; 2021; 11():639408. PubMed ID: 34094922
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinoma.
Xu GH; Lou N; Shi HC; Xu YC; Ruan HL; Xiao W; Liu L; Li X; Xiao HB; Qiu B; Bao L; Yuan CF; Zhou YL; Hu WJ; Chen K; Yang HM; Zhang XP
BMC Cancer; 2018 Jan; 18(1):88. PubMed ID: 29357836
[TBL] [Abstract][Full Text] [Related]
19. An increase in long non-coding RNA PANDAR is associated with poor prognosis in clear cell renal cell carcinoma.
Xu Y; Tong Y; Zhu J; Lei Z; Wan L; Zhu X; Ye F; Xie L
BMC Cancer; 2017 May; 17(1):373. PubMed ID: 28545465
[TBL] [Abstract][Full Text] [Related]
20. Fifteen hub genes associated with progression and prognosis of clear cell renal cell carcinoma identified by coexpression analysis.
Wang Y; Chen L; Wang G; Cheng S; Qian K; Liu X; Wu CL; Xiao Y; Wang X
J Cell Physiol; 2019 Jul; 234(7):10225-10237. PubMed ID: 30417363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
